Discussion about this post

User's avatar
Zarayna Pradyer's avatar

No wonder Pfizer was reluctant to disclose the required documents. Thanks for posting, Russell.

Expand full comment
Skip's avatar

Here’s the actual Pzizer report in pdf form as released for the FOIR

5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT

REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf

Not only > 42,000 events reported with known 1223 deaths, but another 11,361 Not recovered at the time of report and another 9400 unknown. That’s 21,984 out of 42,000 ( 52% )

Pg. 29: 5. SUMMARY AND CONCLUSION

Review of the available data for this cumulative PM experience, confirms a favorable

benefit: risk balance for BNT162b2. (Well, yeah, if deaths and tens of thousands reportable adverse reactions don’t count.)

Begriming on pg. 30 there are 9 pages in exceedingly small print of LIST OF ADVERSE EVENTS OF SPECIAL INTEREST. I estimate 3000 - 4000.

Expand full comment
3 more comments...

No posts